The Irish pharmaceutical industry over the boom period and beyond

Irish Geography

Volumn 42, Issue 1, 2009, Pages 23-44

  van Egeraat, Chris ^a   Barry, Frank ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Global production networks; Ireland; Pharmaceutical; R D

Indexed keywords

EMPLOYMENT; MANUFACTURING; PHARMACEUTICAL INDUSTRY; REGIONAL DEVELOPMENT;

EURASIA; EUROPE; IRELAND; WESTERN EUROPE;

EID: 69249129459     PISSN: 00750778     EISSN: None     Source Type: Journal    
DOI: 10.1080/00750770902815604     Document Type: Article

References (64)

1. Agrawall, M., 1999. Global competitiveness in the pharmaceutical industry: the effect of national regulatory, economic and market factors. New York: Pharmaceutical Products Press.
2. Amin, A., Bradley, D., Howells, J., Tomaney, J. and Gentle, C. (1994) Regional incentives and quality of mobile investment in the less favoured regions of the EC. Progress in Planning, 41:1, pp. 1-112.
3. Azoulay, P., 2003. Acquiring knowledge within and across firm boundaries: evidence from clinical development. NBER working paper 10083. Cambridge: National Bureau of Economic Research.
4. Bair, J. and Gereffi, G., 2001. Local clusters in global chains: the causes and consequences of export dynamism in Torreon's blue jeans industry. World Development, 29 (11), 1885-1903.
5. Barry, F., 2005. FDI, transfer pricing and the measurement of R&D-Intensity. Research Policy, 34 (5), 673-681.
6. Barry, F. and van Egeraat, C., 2008. The decline of the computer hardware sector: how Ireland adjusted. ESRI Quarterly Economic Commentary, Spring, 38-57.
7. Bartlett, C. and Ghoshal, S., 1989. Managing across borders. Boston, MA: Harvard Business School Press.
8. Beesley, A., 2005. US firm in €1bn return from Irish unit. Irish Times, 12 October, p. 20.
9. Brennan, C., 2008. Pharma head backs Ireland as base for clinical trials. Irish Times, 25 July, p. 18.
10. Census of Industrial Production, 2004. Dublin: Central Statistics Office.
11. Childs, P., 1996. The chemical industry in Cork. Chemistry in Action, 47.
12. Chiesa, V., 1996. Separating research from development: evidence from the pharmaceutical industry. European Management Journal, 14 (6), 638-647.
13. Coe, N., Hess, M., Yeung, H., Dicken, P., and Henderson, J., 2004. Globalizing regional development: a global production networks perspective. Transactions of the Institute of British Geographers, 29, 464-84.
14. Cooke, P., 2005. Rational drug design: The knowledge value chain and bioscience megacentres. Cambridge Journal of Economics, 29 (3), 325-341.
15. Desai, M., Foley, C.F., and Hines, J.R.Jr., 2006. The demand for tax haven operations. Journal of Public Economics, 90, 513-531.
16. Dicken, P., Kelly, P., Olds, K., and Yeung, H., 2001. Chains and networks, territories and scales: towards a relational framework for analysing the global economy. Global Networks, 1 (2), 89-112.
17. Dicken, P., 2007. Global shift: mapping the changing contours of the world economy. London: Sage Publications.
18. EFPIA, 2003. The pharmaceutical industry in figures. Brussels: European Federation of Pharmaceutical Industries and Associations.
19. Enterprise Strategy Group, 2004. Ahead of the curve: Ireland's place in the global economy. pharmaceutical biotechnology sector report. Dublin: Forf́s;;.
20. Forf́s, 1995. Transport needs of Irish manufacturing sectors. Dublin: Forf́s.
21. Forf́s, 2003. The Supply and demand for skills in the biotechnology sector. Dublin: Forf́s.
22. Galvin, S., 1998. The chemical industry in Ireland. Chemistry in Action, 54, 9-16.
23. Gerreffi, G., 2001. Shifting governance structures in global commodity chains, with special reference to the internet. American Behavioural Scientist, 44 (10), 1616-1637.
24. Gereffi, G. and Korzeniewicz, M., eds., 1994. Commodity chains and global capitalism. Westport, CT: Praeger Publishers.
25. Hayter, R., 1998. Research and development. In: P. Daniels and W. Lever, eds. The global economy in transition. Harlow, UK: Longman, 64-190.
26. Hedlund, G. and Rolander, D., 1990. Actions in heterarchies: new approaches to managing the MNE. In: C. Bartlett, Y. Doz and G. Hedlund, eds. Managing the global firm. London: Routledge, 15-46.
27. Henderson, J., Dicken, P., Hess, M., Coe, N., and Yeung, H., 2002. Global production networks and the analysis of economic development. Review of International Political Economy, 9 (3).
28. Hudson, R., 1994. New production concepts, new production geographies? Reflections on changes in the automobile industry. Transactions of the Institute of British Geographers, 19 (3), 331-345.
29. Hudson, R., 1997. Regional futures: industrial restructuring, new high volume production concepts and spatial development strategies in the new Europe. Regional Studies, 31 (5), 467-478.
30. Howells, J., 1992. Pharmaceuticals and Europe 1992. Environment and Planning A, 24, 33-48.
31. Howells, J., 1984. The location of research and development: some observations and evidence from Britain. Regional Studies, 18 (1), 13-29.
32. ICSTI, 1999. Technology foresight Ireland. Dublin: Irish Council for Science Technology and Innovation.
33. ICSTI, 2003. Embedding the pharmachem industry in Ireland. Dublin: Irish Council for Science Technology and Innovation.
34. International Trade Centre online database, available at http://www.intracen.org.
35. Jungmittag, A. and Reger, G., 2000. Dynamics of the markets and market structure. In: A. Jungmittag, G. Reger and T. Reiss, eds. Changing innovation in the pharmaceutical industry: globalisation and new ways of drug development. Berlin: Springer-Verlag, 27-47.
36. Lane, C. and Probert, J., 2005. Innovation systems, globalisation and performance in the pharmaceutical industry: German and UK firms compared. Paper presented at the conference Organisational Configurations and Locational Choices of Firms: Responses to Globalisation in Different Industry and Institutional Environments. University of Cambridge, 14-15 April.
37. Malecki, E., 1997. Technology & economic development: the dynamics of local, regional and national competitiveness. Harlow, UK: Addison Wesley Longman.
38. McCall, B., 2004. A dose of good medicine. Irish Times, 2 July, p. B6.
39. Phelps, N., 1993. Contemporary industrial restructuring and linkage change in an older industrial region: examples from the Northeast of England. Environment and Planning A, 25 (6), 863-882.
40. Pike, A., 1998. Making performance plants from branch plants? In situ restructuring in the automobile industry in the United Kingdom. Environment and Planning A, 30 (5), 881-900.
41. Piore, M. and Sabel, C., 1984. The second industrial divide. New York: Basic Books.
42. Population Census, 2006. Dublin: Central Statistics Office.
43. Reger, G., 2000. Internationalisation of Research and development in pharmaceuticals. In: A. Jungmittag, G. Reger and T. Reiss, eds. Changing innovation in the pharmaceutical industry: globalisation and new ways of drug development. Berlin: Springer-Verlag, 97-134.
44. Samsonov, M., 2005. Clinical trials in Central and Eastern Europe. World Pharmaceutical Frontiers, 2004/2005, pp. 74-75.
45. Schofield, M., 2001. The global pharmaceutical industry. In: P. Kirkbride, ed. Globalisation: the external pressures. New York: John Wiley.
46. Schweitzer, S., 1997. Pharmaceutical economics and policy. New York: Oxford University Press.
47. Stewart, J., 1989. Transfer pricing: some empirical evidence from Ireland. Journal of Economic Studies, 16 (3), 40-56.
48. Sturgeon, T., 2000. How do we define value chains? MIT IPC Globalization Working Paper 00- 010. Boston: MIT.
49. Taggart, J., 1993. The world pharmaceutical industry. London: Routledge.
50. Turok, I., 1993. Inward investment and local linkages: how deeply embedded is 'Silicon Glen'? Regional Studies, 27(5), 401-417.
51. United Nations Comtrade online database, available at http://comtrade.un.org.
52. van Egeraat, C., 2006. Spatial concentration in the Irish pharmaceutical industry: the role of government intervention and agglomeration economies. NIRSA Working Paper 28. Maynooth, Ireland: National University of Ireland.
53. van Egeraat, C., 2007. The scale and scope of process R&D in the Irish pharmaceutical industry. NIRSA Working Paper 32. Maynooth, Ireland: National University of Ireland.
54. van Egeraat, C. and Breathnach, P., 2007. The manufacturing sector. In: R. Kitchin and B. Bartley, eds. Understanding contemporary Ireland. Dublin: Pluto Press, 125-146.
55. van Egeraat, C. and Breathnach, P., 2008. The drivers of transnational subsidiary evolution: the upgrading of process R&D in the Irish pharmaceutical industry. NIRSA Working Paper 38. Maynooth, Ireland: National University of Ireland.
56. van Egeraat, C. and Jacobson, D., 2004. The rise and demise of the Irish and Scottish computer hardware industry. European Planning Studies, 12 (6), 810-834.
57. White, P., 2000a. The muscles of the Celtic Tiger: IDA's winning sectors. In: R. Mac Sharry and P. White, eds. The making of the Celtic Tiger. Cork: Mercier Press, 272-308.
58. White, P., 2000b. The evolution of the IDA. In: R. Mac Sharry and P. White, eds. The making of the Celtic Tiger. Cork: Mercier Press, 183-197.
59. White, R. and Poynter, T., 1984. Strategies for foreign owned subsidiaries in Canada. Business Quarterly, 49 (summer), 59-69.
60. Yeung, H., 2000. Organizing the firm in industrial geography: networks, institutions and regional development. Progress in Human Geography, 24 (2), 301-315.
61. rd Annual Global Development Conference on Blending Local and Global Knowledge. Sofitel Rio Palace Hotel, Rio de Janeiro, Brazil, 9-12 December.
62. Young, S., Hood, N., and Dunlop, S., 1988. Global strategies, multinational subsidiary roles and economic impact in Scotland. Regional Studies, 22(6), 487-497.
63. Young, S., Hood, N., and Peters, E., 1994. Multinational enterprises and regional economic development. Regional Studies, 28(7), 657.
64. Zeller, C., 2004. North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas. Economic Geography, 80 (1), 83-111.